StemGen, Inc.
SGNI · OTC
3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $114,175 | $114,176 | $68,505 | $45,393 |
| - Cash | $23 | $0 | $39 | $1 |
| + Debt | $563 | $563 | $563 | $563 |
| Enterprise Value | $114,715 | $114,739 | $69,029 | $45,955 |
| Revenue | $0 | $20 | $0 | $10 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | -$4 | $7 | $0 | $5 |
| % Margin | – | 35.8% | – | 50% |
| EBITDA | -$133 | -$27 | -$83 | -$37 |
| % Margin | – | -136.7% | – | -372.4% |
| Net Income | -$199 | -$117 | -$171 | -$169 |
| % Margin | – | -582.9% | – | -1,685.9% |
| EPS Diluted | -0.004 | -0.003 | -0.004 | -0.004 |
| % Growth | -69.2% | 29.7% | 0% | – |
| Operating Cash Flow | -$144 | -$40 | -$66 | -$10 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$144 | -$40 | -$66 | -$10 |